Sg Americas Securities, LLC Fibrogen Inc Transaction History

Sg Americas Securities, LLC

  • $27.6 Billion
  • Q3 2024

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024
SELL
$0.73 - $2.73 $58,430 - $218,514
-80,042 Reduced 70.97%
32,741 $77,000
Q4 2023

Jan 12, 2024
BUY
$0.38 - $0.91 $19,027 - $45,566
50,073 Added 79.85%
112,783 $100,000
Q3 2023

Oct 13, 2023
BUY
$0.79 - $2.83 $41,267 - $147,830
52,237 Added 498.78%
62,710 $54,000
Q2 2023

Jul 10, 2023
SELL
$2.49 - $20.59 $137,607 - $1.14 Million
-55,264 Reduced 84.07%
10,473 $28,000
Q1 2023

Apr 28, 2023
BUY
$15.95 - $25.18 $520,560 - $821,799
32,637 Added 98.6%
65,737 $1.23 Million
Q4 2022

Feb 02, 2023
SELL
$13.27 - $17.73 $125,335 - $167,459
-9,445 Reduced 22.2%
33,100 $530,000
Q3 2022

Oct 31, 2022
SELL
$11.4 - $14.6 $178,592 - $228,723
-15,666 Reduced 26.91%
42,545 $554,000
Q2 2022

Jul 29, 2022
BUY
$7.94 - $12.96 $325,921 - $531,982
41,048 Added 239.17%
58,211 $615,000
Q1 2022

Apr 29, 2022
SELL
$12.02 - $16.79 $260,028 - $363,218
-21,633 Reduced 55.76%
17,163 $206,000
Q4 2021

Feb 07, 2022
SELL
$9.93 - $15.39 $238,399 - $369,483
-24,008 Reduced 38.23%
38,796 $547,000
Q3 2021

Nov 01, 2021
BUY
$10.18 - $26.64 $340,582 - $891,267
33,456 Added 114.0%
62,804 $642,000
Q2 2021

Aug 12, 2021
SELL
$18.57 - $35.68 $449,449 - $863,563
-24,203 Reduced 45.2%
29,348 $782,000
Q1 2021

May 13, 2021
SELL
$31.0 - $55.72 $943,764 - $1.7 Million
-30,444 Reduced 36.25%
53,551 $1.86 Million
Q4 2020

Feb 04, 2021
BUY
$37.09 - $48.97 $1.68 Million - $2.21 Million
45,221 Added 116.63%
83,995 $3.12 Million
Q3 2020

Nov 09, 2020
SELL
$40.47 - $45.5 $980,749 - $1.1 Million
-24,234 Reduced 38.46%
38,774 $1.59 Million
Q2 2020

Jul 20, 2020
BUY
$32.57 - $42.83 $1.46 Million - $1.91 Million
44,681 Added 243.8%
63,008 $2.55 Million
Q1 2020

Apr 30, 2020
BUY
$23.3 - $45.96 $118,480 - $233,706
5,085 Added 38.4%
18,327 $637,000
Q4 2019

Jan 28, 2020
BUY
$34.58 - $48.06 $104,708 - $145,525
3,028 Added 29.65%
13,242 $568,000
Q3 2019

Nov 04, 2019
SELL
$36.98 - $48.45 $93,115 - $121,997
-2,518 Reduced 19.78%
10,214 $378,000
Q2 2019

Jul 29, 2019
BUY
$35.13 - $55.53 $50,833 - $80,351
1,447 Added 12.82%
12,732 $575,000
Q1 2019

Apr 29, 2019
BUY
$42.83 - $59.91 $222,887 - $311,771
5,204 Added 85.58%
11,285 $613,000
Q4 2018

Feb 01, 2019
BUY
$37.97 - $60.16 $230,895 - $365,832
6,081 New
6,081 $281,000
Q3 2018

Nov 06, 2018
SELL
$56.3 - $67.25 $231,224 - $276,195
-4,107 Closed
0 $0
Q2 2018

Aug 07, 2018
SELL
$44.9 - $64.95 $280,355 - $405,547
-6,244 Reduced 60.32%
4,107 $257,000
Q1 2018

May 03, 2018
SELL
$45.35 - $61.65 $688,685 - $936,216
-15,186 Reduced 59.47%
10,351 $478,000
Q4 2017

Jan 24, 2018
BUY
$41.95 - $60.1 $483,725 - $693,013
11,531 Added 82.33%
25,537 $1.21 Million
Q3 2017

Nov 07, 2017
BUY
$33.4 - $53.9 $467,800 - $754,923
14,006
14,006 $754,000

Others Institutions Holding FGEN

# of Institutions
82
Shares Held
47.1M
Call Options Held
387K
Put Options Held
672K
View Full List

About FIBROGEN INC

FGEN Quotes by TradingView
  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $32.8M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email